Skip to content

Released May 5, 2026, before the open

10-Q filed May 5, 2026, 35 days after period end · 0001193125-26-205003

Q1 2026 · 10-Q
Revenue$196.71M+1.6% vs Q1 2025−10.6% vs Q4 2025
Net Income-$20.91MN/M vs Q1 2025N/M vs Q4 2025
EPS Diluted-$0.52N/M vs Q1 2025no prior Q4 2025 on file
Gross Profit$139,546,000+14.7%
Operating Income-$14,436,000N/M
Operating Cash Flow-$17,610,000N/M
Free Cash Flowderived-$28,271,000N/M
Margins · derived
Gross margin70.9%+8.1 pt vs Q1 2025
Operating margin-7.3%+17.9 pt vs Q1 2025
Net margin-10.6%+16.8 pt vs Q1 2025

What the release said

The release

Same quarter

MetricQ1 2026Q1 2025Q1 2024Q1 2023
Revenue$196.71M$193.65M$188.61M$175.20M
Net Income-$20.91M-$53.09M-$36.02M-$60.94M
EPS Diluted-$0.52-$1.35-$0.95-$1.71

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR